Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder

Journal of Affective Disorders

Volumn 124, Issue 3, 2010, Pages 335-340

  Smesny, Stefan ^a   Baur, Kati ^a   Rudolph, Nicole ^a,b   Nenadic, Igor ^a   Sauer, Heinrich ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Department of Psychiatry ^*  (Switzerland)

Author keywords

HPA axis; Major depression; Niacin skin test; Polyunsaturated fatty acids; Prostaglandin signalling; Unipolar depressive disorder

Indexed keywords

MIRTAZAPINE; NICOTINIC ACID METHYL ESTER; POLYUNSATURATED FATTY ACID; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLUSHING; FOREARM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; SIDE EFFECT; SKIN SENSITIVITY; SPECTROSCOPY; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FATTY ACIDS, UNSATURATED; FEMALE; FLUSHING; HUMANS; MALE; MIDDLE AGED; NIACIN; PATCH TESTS; PERSONALITY INVENTORY; PSYCHOMETRICS; PSYCHOPATHOLOGY; RECURRENCE; YOUNG ADULT;

EID: 77953806967     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.12.017     Document Type: Article

References (40)

1. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 Suppl (1996) S157-S161
2. Beck, A.T., Steer, R.A., 1995. Beck-Depression-Inventar: (BDI). In: Hautzinger M. [Hrsg.], Bailer M, Worall H, Keller F: Testhandbuch. 2, überarbeitete Auflage.
3. Berger G., and McGorry P. The topical niacin flush test - a new assessment scale. World J. Biol. Psychiatry 2 (2001) 134S-135S
4. Bosveld-van Haandel L., Knegtering R., Kluiter H., and van den Bosch R.J. Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res. 143 (2006) 303-306
5. Edwards R., Peet M., Shay J., and Horrobin D. Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. Biochem. Soc. Trans. 26 (1998) S142
6. Edwards R., Peet M., Shay J., and Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48 (1998) 149-155
7. Glen A.I., Cooper S.J., Rybakowski J., Vaddadi K., Brayshaw N., and Horrobin D.F. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 9-15
8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
9. Hibbeln J.R. Fish consumption and major depression. Lancet (1998) 12-13
10. Hibbeln J.R., and Salem Jr. N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am. J. Clin. Nutr. 62 (1995) 1-9
11. Kaplan C.P., Miner M.E., Mervis L., Newton H., McGregor J.M., and Goodman J.H. Interpretive risks: the use of the Hopkins Symptom Checklist 90-Revised (SCL 90-R) with brain tumour patients. Brain Inj. 12 (1998) 199-205
12. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., and Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 85 (1999) 275-291
13. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., and Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 38 (1996) 35-46
14. Marangell L.B., Martinez J.M., Zboyan H.A., Kertz B., Kim H.F.S., and Puryear L.J. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 160 (2003) 996-998
15. Murck H., Song C., Horrobin D.F., and Uhr M. Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. Int. J. Neuropsychopharmacol. 7 (2004) 1-9
16. Nemets B., Stahl Z., and Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry 159 (2002) 477-479
17. Nieminen L.R., Makino K.K., Mehta N., Virkkunen M., Kim H.Y., and Hibbeln J.R. Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 309-314
18. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 10 (1962) 799-812
19. Parker G., Gibson D., Brockie H.C., Heruc G., Rees A.-M., and Hadzi-Pavloivic D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 163 (2006) 969-978
20. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 477-485
21. Peet M., and Horrobin D.F. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch. Gen. Psychiatry 59 (2002) 913-919
22. Peet M., Laugharne J.D., Horrobin D.F., and Reynolds G.P. Arachidonic acid: a common link in the biology of schizophrenia?. Arch. Gen. Psychiatry 51 (1994) 665-666
23. Peet M., Murphy B., Shay J., and Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry 43 (1998) 315-319
24. Ross B. Fatty acids and anxiety disorders. Neurobiol. Lipids 7 (2009) 7
25. Ross B.M., Ward P., and Glen I. Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder. J. Affect. Disord. 82 (2004) 285-290
26. Rybakowski J., and Weterle R. Niacin test in schizophrenia and affective illness. Biol. Psychiatry 29 (1991) 834-836
27. Smesny S., Berger G., Rosburg T., Riemann S., Riehemann S., McGorry P., and Sauer H. Potential use of the topical niacin skin test in early psychosis - a combined approach using optical reflection spectroscopy and a descriptive rating scale. J. Psychiatr. Res. 37 (2003) 237-247
28. Smesny S., Klemm S., Stockebrand M., Grunwald S., Gerhard U.J., Rosburg T., Sauer H., and Blanz B. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 79-85
29. Smesny S., Riemann S., Riehemann S., Bellemann M.E., and Sauer H. Quantitative measurement of induced skin reddening using optical reflection spectroscopy-methodology and clinical application. Biomed. Tech. 46 (2001) 280-286
30. Smesny S., Rosburg T., Baur K., Rudolph N., and Sauer H. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. Neuropsychopharmacology 32 (2007) 2067-2073
31. Smesny S., Rosburg T., Klemm S., Riemann S., Baur K., Rudolph N., Grunwald S., and Sauer H. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. J. Psychiatr. Res. 38 (2004) 537-543
32. Smesny S., Rosburg T., Riemann S., Baur K., Rudolph N., Berger G., and Sauer H. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 72 (2005) 393-402
33. Sublette M.E., Hibbeln J., Galfalvy H., Oquendo M.A., and Mann J.J. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicidal risk. Am. J. Psychiatry 163 (2006) 1100-1102
34. Tavares H., Yacubian J., Talib L.L., Barbosa N.R., and Gattaz W.F. Niacin test in schizophrenia and in major depression. World J. Biol. Psychiatry 2 (2001) 138S
35. Tavares H., Yacubian J., Talib L.L., Barbosa N.R., and Gattaz W.F. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr. Res. 61 (2003) 1-6
36. Tiemeier H., Tuijl R., Hofman A., Kiliaan A.J., and Breteler M.B. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 78 (2003) 40-46
37. Transkanen A., Hibbeln J.R., Hintikka J., Haatainen K., Honkalampi K., and Viinamäki H. Fish consumption, depression, and suicidality in a general population. Arch. Gen. Psychiatry 58 (2001) 512-513
38. Ward P., and Glen I. Niacin skin response and phospholipids in psychiatry. World J. Biol. Psychiatry 2 (2001) 396S
39. Ward P.E. Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 65-68
40. Wittchen H.-U., Fydrich T., and Zaudig M. Strukturiertes Klinisches Interview für DSM-IV (1979), Hogrefe Verlag, Göttingen